Eligini Sonia, Gianazza Erica, Veglia Fabrizio, Brocca Lisa, Cavallotti Laura, Papaianni Giulia Giusy, Andreini Daniele, Pepi Mauro, Polvani Gianluca, Tremoli Elena, Parolari Alessandro, Agostoni Piergiuseppe, Banfi Cristina
Unit of Functional Proteomics, Metabolomics and Network Analysis, Centro Cardiologico Monzino IRCCS, Milano, Italy.
Centro Cardiologico Monzino IRCCS, Milan, Italy.
JACC Adv. 2025 Sep 3;4(10 Pt 2):102119. doi: 10.1016/j.jacadv.2025.102119.
Coronary artery bypass graft (CABG) surgery is performed in patients with complex multivessel coronary artery disease, but long-term graft occlusion remains a major limitation. The immature surfactant protein type-B (proSP-B) has emerged as a predictor of adverse cardiovascular outcomes.
The purpose of this study was to examine the relationship between preoperative plasma proSP-B and graft occlusion 18 months post-CABG. The aims were to evaluate whether elevated proSP-B could predict graft occlusion and to assess its predictive value within a multivariable model for long-term graft patency.
We evaluated proSP-B in relation to graft occlusion in 40 patients with occluded grafts (cases) and 130 patients without occlusions (noncases), with 18-month graft patency assessed by coronary computed tomography angiography and/or invasive angiography. Logistic regression assessed the association between proSP-B and graft occlusion. Predictive performance was evaluated using receiver-operating characteristic curves and category-free net reclassification improvement.
Preoperative proSP-B was significantly elevated in cases compared to noncases (24.0 [IQR: 19.8-31.0] AU vs 19.4 [IQR: 14.0-25.0] AU; P = 0.002). In a multivariable analysis, proSP-B associated with increased risk of graft occlusion, even after adjusting for factors like D-dimer, left ventricular ejection fraction, and extracorporeal circulation time. Including proSP-B in a reference model improved the area under the curve from 0.7204 to 0.7733, significantly enhancing patient classification (net reclassification improvement = 0.43; SE = 0.18; P = 0.02).
Elevated preoperative proSP-B is independently associated with 18-month graft occlusion following CABG. Including proSP-B improves existing predictive models, supporting its role as a novel biomarker for risk stratification in surgical revascularization.
冠状动脉旁路移植术(CABG)用于治疗复杂的多支冠状动脉疾病患者,但长期移植血管闭塞仍然是一个主要限制因素。未成熟的表面活性蛋白B(proSP-B)已成为不良心血管结局的预测指标。
本研究旨在探讨冠状动脉旁路移植术后18个月时术前血浆proSP-B与移植血管闭塞之间的关系。目的是评估proSP-B升高是否可预测移植血管闭塞,并评估其在多变量模型中对长期移植血管通畅的预测价值。
我们评估了40例移植血管闭塞患者(病例组)和130例无闭塞患者(非病例组)的proSP-B与移植血管闭塞的关系,通过冠状动脉计算机断层扫描血管造影和/或有创血管造影评估18个月时的移植血管通畅情况。逻辑回归分析评估proSP-B与移植血管闭塞之间的关联。使用受试者工作特征曲线和无类别净重新分类改善来评估预测性能。
与非病例组相比,病例组术前proSP-B显著升高(24.0 [四分位间距:19.8 - 31.0] AU对19.4 [四分位间距:14.0 - 25.0] AU;P = 0.002)。在多变量分析中,即使在调整了D-二聚体、左心室射血分数和体外循环时间等因素后,proSP-B仍与移植血管闭塞风险增加相关。将proSP-B纳入参考模型可使曲线下面积从0.7204提高到0.7733,显著改善患者分类(净重新分类改善 = 0.43;标准误 = 0.18;P = 0.02)。
术前proSP-B升高与冠状动脉旁路移植术后18个月的移植血管闭塞独立相关。纳入proSP-B可改善现有的预测模型,支持其作为手术血运重建风险分层新生物标志物的作用。